BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 24013520)

  • 1. Bcl-2 expression is associated with poor prognosis of solitary plasmacytoma of bone.
    Guo S; Zhi Y; Yang H; Yu Y; Wang Y; Zhang J; Wang G; Zhang L; Sun B; Zhang Y
    Ann Hematol; 2014 Mar; 93(3):471-7. PubMed ID: 24013520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT3 mRNA and protein expression in colorectal cancer: effects on STAT3-inducible targets linked to cell survival and proliferation.
    Lassmann S; Schuster I; Walch A; Göbel H; Jütting U; Makowiec F; Hopt U; Werner M
    J Clin Pathol; 2007 Feb; 60(2):173-9. PubMed ID: 17264243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of phosphorylated Stat3, cyclin D1 and Bcl-xL in extramammary Paget disease.
    Liu HJ; Moroi Y; Masuda T; Yasumoto S; Kokuba H; Imafuku S; Koga T; Tetsuya T; Tu YT; Aburatani H; Furue M; Urabe K
    Br J Dermatol; 2006 May; 154(5):926-32. PubMed ID: 16634897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary extramedullary plasmacytoma and multiple myeloma: phenotypic differences revealed by immunohistochemical analysis.
    Kremer M; Ott G; Nathrath M; Specht K; Stecker K; Alexiou C; Quintanilla-Martinez L; Fend F
    J Pathol; 2005 Jan; 205(1):92-101. PubMed ID: 15586381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of biomarkers in squamous cell carcinoma of the tongue: multivariate analysis.
    Vora HH; Shah NG; Patel DD; Trivedi TI; Chikhlikar PR
    J Surg Oncol; 2003 Jan; 82(1):34-50. PubMed ID: 12501167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical analysis with multiple antibodies in search of prognostic markers for clear cell renal cell carcinoma.
    Phuoc NB; Ehara H; Gotoh T; Nakano M; Yokoi S; Deguchi T; Hirose Y
    Urology; 2007 May; 69(5):843-8. PubMed ID: 17482919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of molecular markers in oral squamous cell carcinoma: a multivariate analysis.
    Shah NG; Trivedi TI; Tankshali RA; Goswami JV; Jetly DH; Shukla SN; Shah PM; Verma RJ
    Head Neck; 2009 Dec; 31(12):1544-56. PubMed ID: 19424974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of signal transducer and activator of transcription 3 (Stat 3) pathway in multiple myeloma: Stat 3 activation and cyclin D1 dysregulation are mutually exclusive events.
    Quintanilla-Martinez L; Kremer M; Specht K; Calzada-Wack J; Nathrath M; Schaich R; Höfler H; Fend F
    Am J Pathol; 2003 May; 162(5):1449-61. PubMed ID: 12707028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma cell neoplasms. Review of disease progression and report of a new variant.
    Nolan KD; Mone MC; Nelson EW
    Surg Oncol; 2005 Aug; 14(2):85-90. PubMed ID: 15993050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effect of Bcl-2 and cyclin A2 on adverse recurrence-free survival in stage I non-small cell lung cancer.
    Ko E; Kim Y; Cho EY; Han J; Shim YM; Park J; Kim DH
    Ann Surg Oncol; 2013 Mar; 20(3):1005-12. PubMed ID: 23115005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiotherapy for solitary plasmacytoma of bone and soft tissue: outcomes and prognostic factors.
    Suh YG; Suh CO; Kim JS; Kim SJ; Pyun HO; Cho J
    Ann Hematol; 2012 Nov; 91(11):1785-93. PubMed ID: 22752147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin D1 overexpression is not a specific grouping marker, but may collaborate with CDC37 in myeloma cells.
    Katayama Y; Sakai A; Okikawa Y; Oue N; Asaoku H; Sasaki A; Imanaka F; Tsujimoto T; Takimoto Y; Masuda R; Nakaju N; Otsuki T; Yasui W; Kimura A
    Int J Oncol; 2004 Sep; 25(3):579-95. PubMed ID: 15289859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship of Stat3 and its target gene products with malignancy in human colorectal carcinoma].
    Ma XT; Wang S; Ye YJ; Du RY; Cui ZR
    Ai Zheng; 2003 Nov; 22(11):1135-9. PubMed ID: 14613639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression profile of 11 proteins and their prognostic significance in patients with chronic lymphocytic leukemia (CLL).
    Faderl S; Keating MJ; Do KA; Liang SY; Kantarjian HM; O'Brien S; Garcia-Manero G; Manshouri T; Albitar M
    Leukemia; 2002 Jun; 16(6):1045-52. PubMed ID: 12040436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiotherapy in the treatment of solitary plasmacytoma.
    Jyothirmayi R; Gangadharan VP; Nair MK; Rajan B
    Br J Radiol; 1997 May; 70(833):511-6. PubMed ID: 9227234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Stat3 activation and tumor growth suppression of non-small cell lung cancer by G-quartet oligonucleotides.
    Weerasinghe P; Garcia GE; Zhu Q; Yuan P; Feng L; Mao L; Jing N
    Int J Oncol; 2007 Jul; 31(1):129-36. PubMed ID: 17549413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Apoptosis-related gene expression and its clinical significance of human osteosarcoma].
    Wu X; Chen ZR; Zhang GJ
    Zhonghua Zhong Liu Za Zhi; 2004 Nov; 26(11):678-81. PubMed ID: 15777507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin D1 and bax influence the prognosis after pancreatoduodenectomy for periampullary adenocarcinoma.
    Tomazic A; Pegan V; Ferlan-Marolt K; Pleskovic A; Luzar B
    Hepatogastroenterology; 2004; 51(60):1832-7. PubMed ID: 15532837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-date on solitary plasmacytoma and its main differences with multiple myeloma.
    Di Micco P; Di Micco B
    Exp Oncol; 2005 Mar; 27(1):7-12. PubMed ID: 15812350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expressions of p53, c-MYC, BCL-2 and apoptotic index in human osteosarcoma and their correlations with prognosis of patients.
    Wu X; Cai ZD; Lou LM; Zhu YB
    Cancer Epidemiol; 2012 Apr; 36(2):212-6. PubMed ID: 21890444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.